The Hague Researchers' Peptide Source — HPLC + MS Verified | Regena

Regena Peptides ships HPLC-verified research peptides to The Hague, Netherlands, with tracked 5–14 day courier service and a batch-level certificate of analysis in every parcel. The Hague laboratories order the same catalogue and the same documentation package used across Europe and North America — GLP-1 analogues, growth-hormone secretagogues, regenerative and mitochondrial peptides — with no minimum order and no institutional account required.

The Hague research procurement has historically leaned on undocumented offshore listings and resellers with no verifiable purity data. Regena's model is the opposite: every batch is tested by an independent analytical laboratory before release, the COA is published against the batch number stamped on the vial cap, and the paperwork travels with the shipment so a The Hague laboratory can verify identity and purity before reconstitution.

Local demand around Leiden University Medical Center, the Leiden Bio Science Park and TU Delft laboratories is documentation-heavy, so MSDS, CoO and CoC bundles are prepared ahead of dispatch on request. Coverage across the Centrum, Scheveningen, Leidschendam, Delft, Leiden and the wider Zuid-Holland region runs on the same tracked courier chain, with temperature-buffered mailers sized for the The Hague transit window.

Buying research peptides in The Hague used to mean importing from undocumented offshore suppliers with no batch-level transparency, opaque domestic re-sellers, or compounding pharmacies priced well above research budgets. Regena replaces those with a verified-batch supply chain: vials originate from manufacturing partners with documented process histories, are tested independently before release, and ship tracked from our European hub to The Hague.

For The Hague laboratories the practical effect is shorter project timelines and cleaner experimental risk. A batch ordered Monday is typically on the bench within the week, with the COA already cross-referenced against the vial cap batch number.

The full Regena catalogue is available for The Hague delivery: GLP-1 agonists (semaglutide, tirzepatide, retatrutide), GH secretagogues (CJC-1295, ipamorelin, tesamorelin, MK-677 reference), regenerative compounds (BPC-157, TB-500, GHK-Cu, KPV) and mitochondrial peptides (MOTS-c, SS-31). Bacteriostatic water, sterile water and mixing supplies can be added to the same order.

Every The Hague shipment includes the printed COA, batch number, lot number and compound-specific reconstitution guidance. Coverage includes the Centrum, Scheveningen, Leidschendam, Delft, Leiden and the wider Zuid-Holland region.

The Hague orders ship with tracked courier service from our European hub. Standard transit is 5–14 day; express options are available through the consultations team. Vials travel in temperature-buffered mailers sized for the The Hague transit window so lyophilised product arrives within specification — refrigerate at 2–8 °C on arrival.

Residential laboratory addresses, co-working benches and registered research-entity addresses are all accepted in The Hague. Signature on delivery is the default; safe-place handling is accepted with prior written request.

Every vial dispatched to The Hague ties back to an independent third-party COA hosted on the Regena lab reports page. Janoshik Analytical is the default verifier; orthogonal laboratories are used when batch chemistry calls for second-method confirmation. Minimum specification is ≥99.0% HPLC main-peak purity with matching mass-spectrometry molecular weight.

The Hague researchers should verify three things before reconstitution: the batch number on the vial cap matches the COA, the COA is dated within the shelf-life window, and the storage conditions described on the COA were respected through the courier chain. The /trust/how-to-read-a-coa guide walks through the full checklist.

The Hague hosts an active life-sciences ecosystem including Leiden University Medical Center, the Leiden Bio Science Park and TU Delft laboratories, and Regena's batch documentation is formatted to slot directly into institutional procurement and ethics processes. MSDS, CoO and CoC documentation is supplied on request before dispatch.

For multi-batch The Hague programmes the consultations team will reserve inventory against a project timeline so a The Hague laboratory is not exposed to the wider catalogue's shifting availability.

Lyophilised peptides delivered to The Hague should be held at 2–8 °C on arrival; long-term storage at −20 °C is appropriate for batches that will not be reconstituted within 8–12 months. Reconstitution with bacteriostatic water (0.9% benzyl alcohol) supports a two-month (60-day) in-use stability window under refrigeration for most analogues.

Aliquot before any freeze; the single most common cause of measurable potency loss in long-acting analogues is repeat freeze-thaw cycling. Vortex gently, never shake aggressively, and keep reconstituted vials away from direct light.

All peptides shipped to The Hague are supplied strictly for in-vitro and preclinical research use. They are not medicines, are not approved for human consumption, and are not dispensed against a prescription. The research-use declaration is included with every The Hague shipment alongside the COA.

Customs handling is pre-cleared from the European hub so The Hague researchers do not face surprise duties or extended border holds. The consultations team will confirm any project-specific documentation question before dispatch.

A free 20-minute consultation is available to every The Hague researcher: compound selection, batch availability, COA review, reconstitution workflow and any project-specific sourcing question. The Regena scientific team takes consultations directly.

Book through the /consultations page; the team responds within one working day across The Hague.